All In Biotech

Free tool

FAERS Monitor: Simulect

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 103764 or its brand name (Simulect, Basiliximab). Reports on generic versions are filed under their own applications.

Reports

11,930

Serious

11,655

98% of reports

Hospitalization

4,993

Death reported

2,541

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use1,081
  • cytomegalovirus infection929
  • drug ineffective918
  • transplant rejection874
  • kidney transplant rejection786
  • pyrexia623
  • product use in unapproved indication542
  • blood creatinine increased522
  • diarrhoea520
  • renal impairment467
  • acute kidney injury462
  • anaemia457
  • thrombotic microangiopathy447
  • multiple organ dysfunction syndrome439
  • sepsis437

Reports by year received

View as table
YearReports
200487
200569
200679
2007105
2008180
2009172
2010201
2011314
2012335
2013305
2014462
2015447
2016532
2017622
2018864
20191,086
20201,009
2021801
2022732
2023799
20241,237
2025901
2026589

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,042,229 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
kidney transplant rejectionSignal786345.1320.4225,324
transplant rejectionSignal874215.7201.5166,273
cytomegalovirus infectionSignal929104.397.989,725
thrombotic microangiopathySignal44784.777.235,216
multiple organ dysfunction syndromeSignal43927.725.311,128
blood creatinine increasedSignal52214.213.16,362
renal impairmentSignal4679.99.03,699
sepsisSignal4376.96.32,215
acute kidney injurySignal4625.34.91,630
anaemiaSignal4574.23.91,132
product use in unapproved indicationSignal5423.93.61,158
pyrexiaSignal6233.22.9942
off label useSignal1,0812.22.1717
diarrhoea5201.41.366
drug ineffective9181.21.241

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.